About Igenomix
Igenomix is a company based in Paterna (Spain) founded in 2009 was acquired by Vitrolife in July 2021. Igenomix has completed 1 acquisition, including Access Genomics.
- Headquarter Paterna, Spain
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
EQT
& 3 more
-
Employee Count
Not available
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Igenomix
Unlock access to complete
Funding Insights of Igenomix
Investors in Igenomix
Igenomix has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include EQT, Vitrolife and Amadeus Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage deep technology investments are made by Amadeus Capital.
|
Locked | Locked | Locked | |
|
EQT is recognized as a global investment organization focused on value creation.
|
Locked | Locked | Locked | |
|
A European mid-market private equity fund is operated.
|
Locked | Locked | Locked |
Investor details for Igenomix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Igenomix
Igenomix has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Access Genomics.
Investment portfolio details for Igenomix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diagnostic tests for clinical genomic solutions are provided.
|
Locked | Locked | 2016 | Locked |
Complete acquisition details for Igenomix
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Igenomix
Detailed financials for Igenomix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Igenomix Comparisons
Peer comparison for Igenomix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Igenomix
Detailed competitors of Igenomix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Igenomix
Complete news archive for Igenomix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Igenomix
Igenomix was founded in 2009 and raised its 1st funding round 7 years after it was founded.
Igenomix is headquartered in Paterna, Spain. It is registered at Paterna, Valencian Community, Spain.
Igenomix was founded in 2009 in Paterna, Spain, as a medical testing laboratory. Operations are conducted in the reproductive genetics sector, with genetic tests including PGT-A, ERA, and CGT offered to reproductive health professionals. Diagnosis and treatment of patients are supported through these services. A global presence is maintained, with activities spanning multiple countries.
Igenomix has made 1 acquisition, including Access Genomics.
Igenomix has 4 investors. Key investors include EQT, Vitrolife, Amadeus Capital Partners, and Charme Capital Partners.